MET in gastric cancer – discarding a 10% cutoff rule

AIMS: We aimed to develop a putative predictive biomarker score for future hepatocyte growth factor receptor (MET)‐targeted therapy of gastric cancer (GC). METHODS AND RESULTS: MET expression and MET amplification were analysed by immunohistochemistry (IHC) and chromogenic in‐situ hybridization (CIS...

Descripción completa

Detalles Bibliográficos
Autores principales: Metzger, Marie‐Luise, Behrens, Hans‐Michael, Böger, Christine, Haag, Jochen, Krüger, Sandra, Röcken, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744765/
https://www.ncbi.nlm.nih.gov/pubmed/26033401
http://dx.doi.org/10.1111/his.12745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744765/
https://www.ncbi.nlm.nih.gov/pubmed/26033401
http://dx.doi.org/10.1111/his.12745

Ejemplares similares